SalmanRafiPunekarMD

Oncology • New York, NY

Sarcoma, Thoracic Cancer

Hematology and Oncology

Join to view full profile

Dr. Punekar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Punekar's full profile

Already have an account?

Office
160 E 34th St
New York, NY 10016
Phone+1 212-731-6228

Fax+1 212-731-5520

Education & Training

NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2018 - 2021
Yale-New Haven Medical CenterResidency, Internal Medicine, 2014 - 2016
Yale-New Haven Medical CenterInternship, Internal Medicine, 2012 - 2013
Drexel University College of MedicineClass of 2011

Certifications & Licensure

NY State Medical License 2018 - 2025
CT State Medical License 2016 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

11 citations
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort St...
Amin H Nassar, So Yeon Kim, Jacqueline V Aredo, Jamie Feng, Frances Shepherd
Journal of Thoracic Oncology. 2024-06-01
4 citations
Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma.
Igor Dolgalev, Hua Zhou, Nina Murrell, Hortense Le, Theodore Sakellaropoulos
Nature Communications. 2023-11-08
metabolomics identifies CD38 as an emergent vulnerability in-mutant lung cancer.
Jiehui Deng, David H Peng, David Fenyo, Hao Yuan, Alfonso Lopez
Biorxiv. 2023-04-20

Lectures

Characterization of a novel entity of high-grade well-differentiated colorectal neuroendocrine tumors.
2019 ASCO Annual Meeting - 6/1/2019

Authored Content

WCLC 2021: Cracking the 'Undruggable' KRAS Problem in Lung CancerSeptember 2021

Press Mentions

Which Studies at ASCO 2024 May Change Practice?May 30th, 2024
NYU Langone Health in the News—Wednesday, July 3, 2024July 5th, 2024